Back to Search Start Over

The pivotal role of osteopontin in UV-induced skin inflammation in a mouse model.

Authors :
Kim H
Shin CY
Park CH
Lee DH
Lee SH
Chung JH
Source :
Open biology [Open Biol] 2024 Nov; Vol. 14 (11), pp. 230397. Date of Electronic Publication: 2024 Nov 13.
Publication Year :
2024

Abstract

Osteopontin (OPN) is a pro-inflammatory protein that influences bone remodelling, wound healing, angiogenesis, allergic inflammation, and skin diseases such as psoriasis, contact dermatitis and skin cancer. However, the role of OPN in the skin remains unclear. Therefore, this study aimed to investigate the role of OPN in the skin, particularly in the context of ultraviolet (UV) irradiation-induced inflammation. OPN expression and its effects on inflammatory modulators were assessed in human skin, in a mouse model and in vitro , using a UV source emitting both UVB and UVA radiation, which collectively contribute to UV-induced skin inflammation. OPN expression increased in human and mouse skin after UV irradiation. Compared with wild-type mice, UV irradiation-induced skin phenotypes, such as erythema and skin thickening, were alleviated in OPN <superscript>-/-</superscript> mice. In addition, the number of immune cells recruited to the skin after UV irradiation and the expression of inflammatory cytokines and matrix metalloproteinases (MMPs) were observed to be decreased in the skin of OPN <superscript>-/-</superscript> mice compared with that of wild-type mice. By contrast, the degree of skin inflammation was higher in the hOPN KI mice than in wild-type mice. Treatment with recombinant OPN increased the expression of MMP-1 and inflammatory cytokines in human dermal fibroblasts and epidermal keratinocytes in vitro . Our results suggest that OPN may play a regulatory role in UV-induced skin inflammation.

Details

Language :
English
ISSN :
2046-2441
Volume :
14
Issue :
11
Database :
MEDLINE
Journal :
Open biology
Publication Type :
Academic Journal
Accession number :
39533922
Full Text :
https://doi.org/10.1098/rsob.230397